The use of Eculizumab and Tocilizumab in the treatment of Hyperhemolysis syndrome, a comprehensive literature review.
Saved in:
| Title: | The use of Eculizumab and Tocilizumab in the treatment of Hyperhemolysis syndrome, a comprehensive literature review. |
|---|---|
| Authors: | Aqel A; Hamad Medical Corporation, Internal Medicine, Doha, Qatar., Al-Asa'd Y; Hamad Medical Corporation, Internal Medicine, Doha, Qatar., Al-Kindi S; Department of Haematology, Sultan Qaboos University, Muscat, Oman., Altouk J; Department of Internal Medicine, Bahrain Salmania Hospital, Manama, Bahrain., Zayed AA; Qatif Central Hospital, Qatif, Saudi Arabia., Al-Abdulmalek A; Division of Hematology, McGill University, Montréal, QC, Canada., Yassin MA; Department of Haematology, NCCCR, Hamad Medical Corporation, Doha, Qatar.; College of Medicine, Qatar University, Doha, Qatar. |
| Source: | Frontiers in medicine [Front Med (Lausanne)] 2025 Sep 16; Vol. 12, pp. 1651895. Date of Electronic Publication: 2025 Sep 16 (Print Publication: 2025). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2296-858X |
|---|---|
| DOI: | 10.3389/fmed.2025.1651895 |
